About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 730721, 9 pages
http://dx.doi.org/10.1155/2013/730721
Research Article

Preexisting High Expression of Matrix Metalloproteinase-2 in Tunica Media of Saphenous Vein Conduits Is Associated with Unfavorable Long-Term Outcomes after Coronary Artery Bypass Grafting

1Departments of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, ul. Dluga 1/2, 61-848 Poznan, Poland
2Histology and Embryology, Poznan University of Medical Sciences, ul. Dluga 1/2, 61-848 Poznan, Poland
3Pediatric Cardiology and Nephrology, Poznan University of Medical Sciences, ul. Dluga 1/2, 61-848 Poznan, Poland
4Anesthesiology and Intensive Therapy, Poznan University of Medical Sciences, ul. Dluga 1/2, 61-848 Poznan, Poland

Received 8 June 2013; Accepted 19 August 2013

Academic Editor: Rei Shibata

Copyright © 2013 Bartlomiej Perek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. D. Lopes, G. E. Hafley, K. B. Allen et al., “Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery,” The New England Journal of Medicine, vol. 361, no. 3, pp. 235–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Klinkert, P. N. Post, P. J. Breslau, and J. H. van Bockel, “Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature,” European Journal of Vascular and Endovascular Surgery, vol. 27, no. 4, pp. 357–362, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Pfeiffer, L. Reiher, K. Grabitz et al., “Reconstruction for renal artery aneurysm: operative techniques and long-term results,” Journal of Vascular Surgery, vol. 37, no. 2, pp. 293–300, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. J. A. Friedman and D. G. Piepgras, “Current neurosurgical indications for saphenous vein graft bypass,” Neurosurgical Focus, vol. 14, no. 3, pp. e1–e3, 2003. View at Scopus
  5. J. G. Motwani and E. J. Topol, “Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention,” Circulation, vol. 97, no. 9, pp. 916–931, 1998. View at Scopus
  6. A. Muto, L. Model, K. Ziegler, S. D. D. Eghbalieh, and A. Dardik, “Mechanisms of vein graft adaptation to the arterial circulation—insights into the neointimal algorithm and management strategies,” Circulation Journal, vol. 74, no. 8, pp. 1501–1512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. S. Schwartz, “Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling,” American Journal of Cardiology, vol. 81, no. 7, pp. 14E–17E, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Domanski, C. B. Borkowf, L. Campeau et al., “Prognostic factors for atherosclerosis progression in saphenous vein grafts: The Postcoronary Artery Bypass Graft (Post-CABG) Trial,” Journal of the American College of Cardiology, vol. 36, no. 6, pp. 1877–1883, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. S.-A. Hassantash, B. Bikdeli, S. Kalantarian, M. Sadeghian, and H. Afhar, “Pathophysiology of aortocoronary saphenous vein bypass graft disease,” Asian Cardiovascular and Thoracic Annals, vol. 16, no. 4, pp. 331–336, 2008. View at Scopus
  10. A. K. Mitra, D. M. Gangahar, and D. K. Agrawal, “Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia,” Immunology & Cell Biology, vol. 84, no. 2, pp. 115–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. L. Johnson, G. J. J. M. van Eys, G. D. Angelini, and S. J. George, “Injury induces dedifferentiation of smooth muscle cells and increased matrix-degrading metalloproteinase activity in human saphenous vein,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 7, pp. 1146–1151, 2001. View at Scopus
  12. N. A. Turner, K. T. Hall, S. G. Ball, and K. E. Porter, “Selective gene silencing of either MMP-2 or MMP-9 inhibits invasion of human saphenous vein smooth muscle cells,” Atherosclerosis, vol. 193, no. 1, pp. 36–43, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Crowther, S. Goodall, J. L. Jones, P. R. F. Bell, and M. M. Thompson, “Increased matrix metalloproteinase 2 expression in vascular smooth muscle cells cultured from abdominal aortic aneurysms,” Journal of Vascular Surgery, vol. 32, no. 3, pp. 575–583, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. J. D. Raffetto and R. A. Khalil, “Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease,” Biochemical Pharmacology, vol. 75, no. 2, pp. 346–359, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Johnson, A. H. Baker, K. Oka et al., “Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis,” Circulation, vol. 113, no. 20, pp. 2435–2444, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Murphy, “Tissue inhibitors of metalloproteinases,” Genome Biology, vol. 12, no. 11, article 233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Aravind, B. Saunders, T. Navin et al., “Inhibitory effect of TIMP influences the morphology of varicose veins,” European Journal of Vascular and Endovascular Surgery, vol. 40, no. 6, pp. 754–765, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Goldman, K. Zadina, T. Moritz et al., “Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study,” Journal of the American College of Cardiology, vol. 44, no. 11, pp. 2149–2156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. A. J. Epstein, D. Polsky, F. Yang, L. Yang, and P. W. Groeneveld, “Coronary revascularization trends in the united states, 2001–2008,” The Journal of the American Medical Association, vol. 305, no. 17, pp. 1769–1776, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. G. M. FitzGibbon, H. P. Kafka, A. J. Leach, W. J. Keon, G. D. Hooper, and J. R. Burton, “Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years,” Journal of the American College of Cardiology, vol. 28, no. 3, pp. 616–626, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. M. H. Gault, L. L. Longerich, J. D. Harnett, and C. Wesolowski, “Predicting glomerular function from adjusted serum creatinine,” Nephron, vol. 62, no. 3, pp. 249–256, 1992. View at Scopus
  22. W. Remmele and H. E. Stegner, “Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue,” Pathologe, vol. 8, no. 3, pp. 138–140, 1987. View at Scopus
  23. B. Perek, A. Malinska, M. Nowicki, et al., “Histological evaluation of age-related variations in saphenous vein grafts used for coronary artery bypass grafting,” Archieves of Medical Sciences, vol. 8, no. 6, pp. 1041–1047, 2012.
  24. J. D. Flaherty and C. J. Davidson, “Diabetes and coronary revascularization,” The Journal of the American Medical Association, vol. 293, no. 12, pp. 1501–1508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Endo, Y. Tomizawa, and H. Nishida, “Bilateral versus unilateral internal mammary revascularization in patients with diabetes,” Circulation, vol. 108, no. 11, pp. 1343–1349, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. J. George, A. B. Zaltsman, and A. C. Newby, “Surgical preparative injury and neointima formation increase MMP-9 expression and MMP-2 activation in human saphenous vein,” Cardiovascular Research, vol. 33, no. 2, pp. 447–459, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Yongxin, D. Wenjun, W. Qiang, et al., “Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits,” The Annals of Thoracic Surgery, vol. 95, no. 1, pp. 55–62, 2013.
  28. K. M. Southgate, D. Mehta, M. B. Izzat, A. C. Newby, and G. D. Angelini, “Increased secretion of basement membrane-degrading metalloproteinases in pig saphenous vein into carotid artery interposition grafts,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 7, pp. 1640–1649, 1999. View at Scopus
  29. Z. S. Galis and J. J. Khatri, “Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly,” Circulation Research, vol. 90, no. 3, pp. 251–262, 2002. View at Scopus
  30. R. Pyo, J. K. Lee, J. M. Shipley et al., “Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms,” Journal of Clinical Investigation, vol. 105, no. 11, pp. 1641–1649, 2000. View at Scopus
  31. M. H. Tayebjee, I. Karalis, S. K. Nadar, D. G. Beevers, R. J. MacFadyen, and G. Y. H. Lip, “Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension,” American Journal of Hypertension, vol. 18, no. 3, pp. 325–329, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. W. Chung, A. D. Booth, C. Rose, C. R. Thompson, A. Levin, and C. Van Breemen, “Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction,” Journal of Vascular Research, vol. 45, no. 4, pp. 357–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. P. Spiers, E. J. Kelso, W. F. Siah et al., “Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade,” Journal of Hypertension, vol. 23, no. 9, pp. 1717–1724, 2005. View at Scopus